Search research articles
Contact Us
Filters
Showing results (121-130 of 124) with videos related to
Page
of 13
Sort By:
You have reached the last page of results.
This site can display upto 124 results.
British Journal of Haematology
|
January 14, 1999
Acute and chronic arsenic poisoning associated with treatment of acute promyelocytic leukaemia
S Y Huang, C S Chang, J L Tang, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
June 28, 2012
Gender differences in treatment outcomes of tuberculosis patients in Taiwan: a prospective observational study
J-Y Feng, S-F Huang, W-Y Ting, et al.
Oncogene
|
August 1, 2017
EZH2-mediated upregulation of ROS1 oncogene promotes oral cancer metastasis
C-H Shih, Y-J Chang, W-C Huang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 30, 2015
A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer
J S Chen, C Hsu, N J Chiang, et al.
Page
of 13
Search research articles
Search
Showing results (121-130 of 124) with videos related to
Sort By:
Page
of 13
You have reached the last page of results.
This site can display upto 124 results.
British Journal of Haematology
|
January 14, 1999
Acute and chronic arsenic poisoning associated with treatment of acute promyelocytic leukaemia
S Y Huang, C S Chang, J L Tang, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
June 28, 2012
Gender differences in treatment outcomes of tuberculosis patients in Taiwan: a prospective observational study
J-Y Feng, S-F Huang, W-Y Ting, et al.
Oncogene
|
August 1, 2017
EZH2-mediated upregulation of ROS1 oncogene promotes oral cancer metastasis
C-H Shih, Y-J Chang, W-C Huang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 30, 2015
A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer
J S Chen, C Hsu, N J Chiang, et al.
Page
of 13